ctrl K

Watchlist Price Alert

Prometheus Biosciences In... (RXDX)

NASDAQ: RXDX · Real-Time Price · USD

199.92

0.18 (0.09%)

At close: Jun 15, 2023, 8:00 PM

Prometheus Biosciences Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2017	FY 2016
Period Ending	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2016	Dec 31, 2015
Revenue	6.81M	3.13M	1.23M	1.12M	n/a	n/a
Cost of Revenue	n/a	n/a	n/a	n/a	n/a	n/a
Gross Profit	6.81M	3.13M	1.23M	1.12M	n/a	n/a
Operating Income	-145.78M	-87.8M	-29.01M	-15.97M	-100.68M	-90.58M
Interest Income	4.03M	108K	13K	9K	n/a	n/a
Pretax Income	-141.75M	-90.19M	-31.14M	-16.73M	-103.64M	-92.46M
Net Income	-141.75M	-89.94M	-39.25M	-30.49M	-103.64M	-92.46M
Selling & General & Admin	39.74M	28.5M	11.09M	6.13M	23.76M	17.07M
Research & Development	112.85M	62.43M	19.15M	10.96M	76.93M	73.51M
Other Expenses	4.03M	-2.39M	-15K	n/a	n/a	n/a
Operating Expenses	152.59M	90.93M	30.24M	17.09M	100.68M	90.58M
Interest Expense	n/a	861K	2.13M	770K	3.21M	2.59M
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	152.59M	90.93M	30.24M	17.09M	100.68M	90.58M
Income Tax Expense	-629K	-258K	8.11M	13.76M	259K	715K
Shares Outstanding (Basic)	40.62M	31.33M	34.61M	26.98M	38.48M	26.85M
Shares Outstanding (Diluted)	40.62M	31.33M	34.61M	26.98M	38.48M	26.85M
EPS (Basic)	-3.49	-2.87	-1.13	-1.13	-2.69	-3.44
EPS (Diluted)	-3.49	-2.87	-1.13	-1.13	-2.69	-3.44
EBITDA	-145.78M	-87.8M	-28.9M	-15.92M	-96.95M	-87.83M
EBIT	n/a	-89.33M	-29.01M	-15.96M	-100.42M	-89.86M
Depreciation & Amortization	629K	258K	107K	44K	3.48M	2.04M